METLIFE INC
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
MET$101.67+3.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
Item 8. Financial Statements and Supplementary Data
Index to Consolidated Financial Statements, Notes and Schedules
| Page | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID 34) | 120 |
| Financial Statements at December 31, 2024 and 2023 and for the Years Ended December 31, 2024, 2023 and 2022: | |
| Consolidated Balance Sheets | 123 |
| Consolidated Statements of Operations | 124 |
| Consolidated Statements of Comprehensive Income (Loss) | 125 |
| Consolidated Statements of Equity | 126 |
| Consolidated Statements of Cash Flows | 127 |
| Notes to the Consolidated Financial Statements | |
| Note 1 — Business, Basis of Presentation and Summary of Significant Accounting Policies | 129 |
| Note 2 — Segment Information | 148 |
| Note 3 — Acquisitions and Dispositions | 154 |
| Note 4 — Future Policy Benefits | 154 |
| Note 5 — Policyholder Account Balances | 176 |
| Note 6 — Market Risk Benefits | 190 |
| Note 7 — Separate Accounts | 195 |
| Note 8 — Deferred Policy Acquisition Costs, Value of Business Acquired, Unearned Revenue and Other Intangibles | 199 |
| Note 9 — Reinsurance | 201 |
| Note 10 — Closed Block | 206 |
| Note 11 — Investments | 208 |
| Note 12 — Derivatives | 226 |
| Note 13 — Fair Value | 240 |
| Note 14 — Leases | 254 |
| Note 15 — Goodwill | 255 |
| Note 16 — Long-term and Short-term Debt | 256 |
| Note 17 — Collateral Financing Arrangements | 258 |
| Note 18 — Junior Subordinated Debt Securities | 260 |
| Note 19 — Equity | 261 |
| Note 20 — Other Revenues and Other Expenses | 277 |
| Note 21 — Employee Benefit Plans | 278 |
| Note 22 — Income Tax | 286 |
| Note 23 — Earnings Per Common Share | 289 |
| Note 24 — Contingencies, Commitments and Guarantees | 290 |
| Financial Statement Schedules at December 31, 2024 and 2023 and for the Years Ended December 31, 2024, 2023 and 2022: | |
| Schedule I — Consolidated Summary of Investments — Other Than Investments in Related Parties | 295 |
| Schedule II — Condensed Financial Information (Parent Company Only) | 296 |
| Schedule III — Consolidated Supplementary Insurance Information | 303 |
| Schedule IV — Consolidated Reinsurance | 305 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.